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Abstract
The ability of a soluble heparin-binding oligopeptide sequence derived from the von Willebrand factor (vWF) to modulate
the adhesion and chemokinetic migration behavior of arterial smooth muscle cells was assessed using a novel glass
microsphere centrifugation assay and automated time-lapse fluorescence videomicroscopy, respectively. Treatment of cells
grown on fibronectin-coated substrates with the heparin-binding peptide resulted in the disassembly of focal adhesions, as
assessed by immunohistochemical staining. These observations were consistent with six-fold decrease in cell^substrate
adhesive strength (P6 0.001), a biphasic effect on migration speed (P6 0.05), as well as a dose-dependent reduction in the
percentage of motile cells and the cell dispersion coefficient (W= S2T/2). The specificity of this response to the vWF-derived
heparin-binding peptide was supported by the absence of an observed effect in the presence of either a scrambled peptide or a
consensus heparin-binding peptide sequence of similar heparin affinity. These data support the notion that competitive
interactions between cell surface heparan sulfates with heparin-binding peptide domains located in soluble peptide fragments
may modulate chemokinetic cell migration behavior and other adhesion-related processes. ß 2002 Elsevier Science B.V.
All rights reserved.
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1. Introduction
Cell locomotion, as an essential component of
smooth muscle cell and ¢broblast repair and regen-
erative processes in the vascular wall, is a dynamic
process involving the formation and breakage of at-
tachments to the underlying substrate [1,2]. It is
probable that both short-term interactions, such as
the binding of individual adhesion receptors to sur-
face bound ligand, and longer time-scale events, in-
cluding the clustering of receptors into focal contacts
and stress ¢ber formation are relevant to movement
which occurs over periods ranging from hours to
weeks. For example, DiMilla et al. [3] measured the
attachment strength of vascular smooth muscle cells,
which had been incubated for 30 min with substrates
coated with varying surface densities of matrix pro-
teins, and correlated the strength of short-term adhe-
sive interactions with cell migration. Intermediate cell
attachment strength was associated with both maxi-
mal cell speed and directional persistence. Impor-
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tantly, mathematical models that have evolved in the
context of these observations predict that cell speed
is a function of both cell motile force and the binding
strength to the substratum [4,5]. These studies have
established an important conceptual framework for
understanding the role of adhesive interactions in cell
locomotion. Nonetheless, there remain a number of
important considerations which have received less
attention ^ including the relative contribution of dif-
ferent time-scale adhesive events and the proportion-
ate e¡ect of non-integrin adhesion receptors in deter-
mining cell-binding strength to the underlying matrix.
Of note, current evidence suggests that cell surface
heparan sulfate proteoglycans (HSPGs) promote fo-
cal adhesion formation, thereby enhancing cell/sub-
strate interactions. The role of cell surface heparan
sulfates (HS) in the formation of focal adhesions was
initially suggested by the inability of two mutant cell
lines that lacked or had altered HSPGs to form focal
adhesions in response to a ¢bronectin substrate [6,7].
Prior to these observations, Woods et al. [8] had
demonstrated that substrata coated with the isolated
cell-binding domain of ¢bronectin were not su⁄cient
for complete cell adhesion; cells attached and spread
but did not form focal contacts unless heparin-bind-
ing ¢bronectin sequences were added. Others [9,10]
have also observed that endothelial cells, vascular
smooth muscle cells, and human ¢broblasts are
able to spread on cell-binding RGD containing ¢bro-
nectin fragments but are unable to form actin stress
¢bers or focal contacts if the glycosaminoglycan
(GAG)-binding domain is absent. Pre-treatment of
cells with heparitinase I and III also blocks focal
contact formation [10,11].
In addition to ¢bronectin, interstitial collagens
(type I, III, IV, V, and VIII), as well as von Wille-
brand factor (vWF), laminin, tenascin, thrombo-
spondin, and vitronectin all contain heparan sul-
fate-binding sites. In the setting of direct vascular
wall injury, such as balloon angioplasty, or chronic
injury, such as that induced by sustained hyperten-
sion, many of these HS-binding glycoproteins are
synthesized by activated smooth muscle cells, ¢bro-
blasts, and endothelial cells or released in the process
of platelet degranulation [12^16]. Thus, increased lev-
els of these glycoproteins in the healing vascular
wound yield large numbers of heparan sulfate-bind-
ing sites, which through interactions with cell surface
HSPGs may alter the formation of focal adhesions,
cell adhesiveness, and the generation of traction
forces.
Within this framework, the degradation of HS-
binding glycoproteins by proteases or other factors
may enhance cell motility by both chemotactic and
chemokinetic related mechanisms. For example, the
generation of proteolytic degradation products from
a variety of matrix proteins, including ¢bronectin,
collagen, elastin, and laminin, yield chemotactic pep-
tide fragments [17^21]. In addition, a decrease in cell
adhesiveness may be induced by a direct reduction in
the local concentration of ECM bound ligand for
either members of the integrin receptor family or
cell surface HSPGs. In principle, this reduction in
cell adhesiveness may be further ampli¢ed by the
release of soluble peptides that compete with matrix
bound ligands for cell adhesion receptors. Both of
these e¡ects on cell/substrate adhesiveness ^ a reduc-
tion in bound ligand density and an increase in the
concentration of competing soluble ligands ^ have
the potential to alter chemokinetic cell migration be-
havior. To date, most studies that have investigated
the potential of soluble peptides to e¡ectively com-
pete for cell surface adhesion receptors, have focused
on peptides or protein fragments that contain integ-
rin-binding RGD sequences [22,23]. For example,
Wu et al. [24] demonstrated that an RGD containing
peptide was capable of enhancing chemokinetic cell
motility on substrates containing high surface con-
centrations of ¢bronectin. These results were consis-
tent with an observed reduction in the strength of
short-term adhesive interactions in the presence of
a competing integrin-binding peptide. Since the inter-
action of cell surface HSPGs with matrix bound hep-
arin-binding domains promotes focal adhesion for-
mation, we speculated that the presence of soluble
heparin-binding peptides might also in£uence cell lo-
comotion through direct competitive interactions.
Speci¢cally, we have observed that a heparin-binding
peptide derived from von Willebrand factor (vWF) is
capable of inducing a dose-dependent decrease in cell
adhesive strength and a biphasic e¡ect on chemoki-
netic cell migration speed. This phenomenon appears
to be related, in part, to the disassembly of focal
adhesions.
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2. Materials and methods
2.1. Cell culture techniques
Immortalized rat pulmonary arterial smooth
muscle cells (PAC1) were a gift of Dr. Rothman
(UCSD Medical Center, San Diego, CA, USA)
[25]. Cells were grown in growth media composed
of M199 medium (Mediatech) supplemented with
10% fetal bovine serum (FBS; Hyclone, Logan,
UT, USA), 2 mM L-glutamine (Gibco BRL Life
Technologies, Grand Island, NY, USA), and 1%
antibiotic^antimycotic mixture (Gibco BRL Life
Technologies). Cell quiescence was established by in-
cubation for 24 h in M199 medium with 0.5% FBS
(quiescence medium). All migration and adhesion as-
says were performed in serum-free medium. Serum-
free medium consisted of MCDB 104 (Gibco BRL
Life Technologies) supplemented with 1 mM CaCl2,
10 mg/l insulin, 6.7 Wg/l sodium selenite, 5.5 mg/l
transferrin, 2 mM L-glutamine, and 1% antibiotic^
antimycotic mixture.
2.2. Peptides
All peptides were synthesized in the Emory Uni-
versity Winship Cancer Center Microchemistry Cen-
ter. The heparin-binding peptides used in this study
are derived from the known primary amino acid se-
quence of von Willebrand factor (vWF) [26,27], and
a reported heparin-binding consensus sequence [27].
The peptides were designated as follows: vWF
(KDRKRPSELRRI), scrambled vWF (IKERPRLK-
DRSR), consensus (AKRGLRHRLGRKG), and
scrambled consensus (KLKLRARGRGRGH). In se-
lective cases, an additional tyrosine or cysteine resi-
due was added to the C-terminus of the peptides to
facilitate iodination or £uorescein labeling, respec-
tively. The sequences of the scrambled forms of the
consensus and vWF peptides were designed to evenly
distribute the basic residues throughout the molecule.
Human plasma ¢bronectin (pFN) was obtained from
Sigma (St. Louis, MO, USA.
2.3. Protein adsorption assay
Fibronectin, the 110 kDa ¢bronectin fragment,
collagen type I, and heparin-binding peptides were
radiolabeled with 125I using Iodobeads (Pierce, Rock-
ford, IL, USA) following the manufacturer’s proto-
col. Both the percent of iodine incorporation and
speci¢c activity were determined. We have previously
reported detailed methods for determining the ¢bro-
nectin adsorption pro¢le onto non-tissue culture
treated polystyrene discs [28,29]. The surface density
of other proteins or peptide sequences adsorbed onto
glass coverslips and glass microspheres (d 30^50 Wm;
Polysciences) was ascertained in similar fashion. Ad-
hesion and migration assays, as well as correlative
immunohistochemical staining studies were con-
ducted on a variety of ¢bronectin-coated substrate
types (e.g. glass vs. non-tissue culture polystyrene)
and con¢gurations (e.g. spherical vs. planar surfa-
ces). The determination of an absolute ¢bronectin
surface density on each surface type ensured that
consistent correlations between assays could be as-
certained.
2.4. Immunostaining
Focal adhesion formation and disassembly in the
presence of soluble heparin-binding peptides was ex-
amined in cells cultured on ¢bronectin-coated glass
coverslips. Coverslips (Fisher Scienti¢c, Fairlawn,
NJ, USA) were incubated with pFN for 24 h at
4‡C, followed by three washes with PBS, blocking
with 1% BSA for 45 min at room temperature, and
three more washes with PBS. Cells at 80% con£uency
were detached with trypsin/EDTA and resuspended
in migration medium. Approximately 10 000 cells/
cm2 were seeded on each glass coverslip and were
allowed to adhere and spread overnight prior to
any further treatment. Plated cells were then incu-
bated for an additional 24 h with a test peptide. In
order to visualize focal adhesions, cells were stained
for vinculin with hVIN-1 monoclonal anti-vinculin
antibody (Sigma). Brie£y, the cells were ¢xed with
5 min incubation in 3.7% formaldehyde (Sigma) at
room temperature followed by permeabilization with
1% Triton X-100 for 5 min at room temperature and
three washes for 15 min each with PBS. Slides were
incubated with the anti-vinculin monoclonal anti-
body (1:250 dilution) in a humidi¢ed chamber at
37‡C for 45 min. After three washes with PBS for
15 min each, slides were incubated with donkey anti-
mouse antibody conjugated with rhodamine (Phar-
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mingen, San Diego, CA, USA) in a humidi¢ed
chamber at 37‡C for 45 min. After three washes
with PBS for 15 min each, coverslips were mounted
on pre-cleaned microscope slides and viewed with
a Nikon TMD epi£uorescence microscope under
a 100U objective. In the absence of primary anti-
body, non-speci¢c £uorescent staining was not ob-
served.
2.5. Adhesion assay
Adhesive strength of attached and spread cells was
quanti¢ed using a modi¢ed form of the centrifuga-
tion adhesion assay. Cells grown to 80% con£uency
were detached using trypsin/EDTA and seeded in the
presence of growth media onto the inner six wells of
sterile tissue culture treated detachable 8-well strips
(Corning Costar). Cells were allowed to grow to con-
£uence, at which time the monolayer was washed
three times with PBS, followed by the addition to
each well of 200 Wl of ¢bronectin-coated glass micro-
spheres (dmean 38.5 Wm; s.g. 2.48, Polysciences) and
test peptide, where indicated. After a 6 h incubation
period in 37‡C, 5% CO2 humidi¢ed atmosphere, in-
dividual wells were detached and placed inverted in a
12-well plate pre-¢lled with 0.1% BSA in PBS. The
plate was centrifuged for 1 min at speeds ranging
from 500 to 3500 rpm and each well then was viewed
under a microscope using a 4U objective. The per-
centage of beads remaining attached to the cell layer
was characterized by computing the fraction of the
well surface that remained covered by beads. This
was facilitated by visualizing the wells with high am-
bient light and performing routine image analysis on
the captured image (IPLab Spectrum, Signal Ana-
lytics, Vienna, VA, USA).
The centrifugal force at which 50% of the beads
are detached from the cell surface was computed by
plotting the percent of attached beads as a function
of centrifugal force. The Levenberg^Marquardt
method for non-linear least squares ¢tting was used
to ¢t the data to:
f  f 0
1 expbF3F50 1
where f is the fraction of beads remaining on the cell
monolayer, f0 is the fraction of well surface covered
by beads at zero force, b is the decay slope, F is the
centrifugal force (g), and F50 is the force (g) at which
50% of the beads are detached.
2.6. Single-cell migration assay
All migration assays were performed using a com-
puter-assisted, £uorescence videomicroscopy system,
as described previously [28,29]. Brie£y, cells at ap-
proximately 80% con£uency were labeled with
0.625 Wg/ml DiI in quiescence medium for 24 h. Cells
were then seeded at a density of approximately 1000
cells/cm2 into non-tissue culture treated polystyrene
multi-well plates coated at a de¢ned surface density
with a speci¢c matrix protein. Cells were observed
for 24 h with images obtained at 30 min intervals.
The images were analyzed to determine the location
of the centroids of each cell at each observation time
point.
Average squared displacement as a function of
time interval nvt for each cell was calculated on an
Excel spreadsheet (Microsoft) using the spatial coor-
dinates obtained from image processing and sorted
using a cell tracking program, described in detail
elsewhere [29]. Displacements were converted from
pixels to Wm with the factor C = 1.00 Wm/pixel, mea-
sured using a stage micrometer. IPLab Spectrum uti-
lizes square pixels, negating the need to include a
correction factor for either horizontal or vertical di-
rections. Squared displacements from [x(t), y(t)] to
[x(t+ivt, y(t+ivt)] were calculated using the following
equation:
d2t!tivt  C2fxt ivt3xt2  yt ivt3yt2g
2
To take advantage of all positional information
available, overlapping intervals were used and mean
square distance, Gd2f, was calculated for all possible
time intervals (0.5 to 24 h in 30 min increments). The
resulting list of Gd2f as a function of migration time,
t, was then ¢tted to a persistent random walk model
described by the equation:
Gd2f  nS2 T t3T13e3t=T  3
where S is the cell speed, in Wm/h, T is the persistence
time, in h, and n is the number of dimensions in
which the cell migrates [30]. The experimental data
were ¢tted to the model using the Levenberg^Mar-
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quardt method. The dispersion coe⁄cient (W) was
determined as:
W  1
n
S2T 4
By applying this method to each of the cells
tracked, we were able to determine the mean cell
speed and persistence time, as well as the dispersion
coe⁄cient with standard errors for each assay.
2.7. Statistical analysis
The data were analyzed using the Student^
Newman^Keuls test. The standard error for the
percentage of motile cells was calculated by analyz-
ing independent Bernoulli trials. Statistical sig-
ni¢cance of these data was determined by
utilizing the z-test with the Yates correction for con-
tinuity.
3. Results
3.1. Adsorption of heparin-binding peptides to
¢bronectin-coated substrates
In order to ensure that soluble heparin-binding
peptide sequences were not adsorbed to any signi¢-
cant degree onto test well surfaces, 125I-labeled pep-
tides were utilized in an adsorption study. Glass cov-
erslips, coated with human plasma ¢bronectin and
blocked with BSA, were incubated overnight with
100 WM peptide solutions.
Minimal adsorption of the vWF-derived peptide
was observed on either ¢bronectin or BSA adsorbed
glass coverslips (Fig. 1). Non-speci¢c peptide binding
to surface adsorbed ¢bronectin was greatest for the
heparin-binding consensus sequence. However, the
amount of consensus peptide that adsorbed onto
the surface was negligible compared to that remain-
ing in solution. Indeed, less than 3% of the peptide
added to each well was adsorbed onto coverslips.
However, some degree of interaction between the
consensus sequence and ¢bronectin was observed,
since the adsorption of the consensus sequence in-
creased by nearly 35% in the presence of surface
bound ¢bronectin.
3.2. Disassembly of focal adhesions is induced by
heparin-binding peptides
Cells were allowed to attach and spread on pFN-
coated glass coverslips and subsequently incubated
overnight with 1 WM or 100 WM of consensus or
vWF-derived peptides. Large, well-organized clusters
of vinculin, representing the formation of focal ad-
hesion contacts, were visible on cells seeded on pFN
substrate in the absence of soluble peptide treatment
Fig. 1. Adsorption of heparin-binding peptides to ¢bronectin- or BSA-coated glass surfaces. Radiolabeled peptides were used to quan-
tify the absolute amount of adsorption on test substrates. Each peptide was added at a concentration of 100 Wg/ml. The molar
amount of adsorbed peptide (A) and percentage of the peptide added to each well that was adsorbed (B) onto plates pre-adsorbed
with pFN (solid bars), or BSA (blank bars) are presented.
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(Fig. 2). Focal adhesions were uniformly distributed
over the entire cell area.
Treatment of cells with 1 WM vWF peptide did not
qualitatively a¡ect the formation of focal adhesions.
Well-organized clusters of vinculin, particularly at
the end of actin bundles and around the edge of
the cell membrane remained visible. However, in
the presence of 100 WM vWF peptide, vinculin clus-
ters were no longer detectable. Rather, uniform
staining of the cell, but not the nucleus, by the
anti-vinculin antibody was observed. These levels ap-
peared to be somewhat greater than background
staining. The treatment of cells with the scrambled
vWF peptide did not appear to have any detectable
e¡ect on the formation of focal adhesions. The con-
sensus peptide was not e¡ective in initiating focal
adhesion disassembly (Fig. 3). The size and the loca-
tion of vinculin clusters in the cells treated with the
consensus peptide were not appreciably di¡erent at
either 1 or 100 WM concentrations of peptide or
the respective scrambled sequence. Nor was any dif-
ference noted when compared with untreated con-
trols.
3.3. Smooth muscle cell adhesion is inhibited in
a dose-dependent manner by heparin-binding
peptides
The adhesive strength between cells and adsorbed
¢bronectin-coated glass microspheres, in the presence
or absence of test peptides and respective scrambled
sequences, was de¢ned using a modi¢ed centrifugal
bead assay. Assay development and optimization are
discussed in detail elsewhere [31]. Utilizing optimized
assay conditions, an adhesion pro¢le, which was di-
rectly related to the extent of focal contact forma-
tion, could be determined as a function of soluble
peptide concentration. This analysis allowed expres-
sion of data in terms of the force (g) at which 50% of
the beads are detached, or alternatively, P50, the
pressure (mN/cm2) at which 50% of the beads are
detached. P50 dictates the use of an assumed micro-
sphere^cell contact area.
In the presence of the vWF-derived peptide, a sig-
ni¢cant decrease in cell adhesion strength to ¢bro-
nectin-coated microspheres was observed (Fig. 4, Ta-
ble 1). Indeed, when cells were treated with 100 WM
Fig. 2. Disassembly of focal adhesion by competitive inhibition with heparin-binding vWF peptide (KDRKRPSELRRI). PAC1 cells
seeded on pFN-coated glass coverslips were stained for vinculin to visualize focal adhesion after a 24 h treatment using vWF peptide.
The concentrations used were: no treatment (A), 1 WM vWF (B), 100 WM vWF (C), and 100 WM scrambled vWF
(IKERPRLKDRSR) (D).
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of vWF peptide, a six-fold reduction in the adhesive
strength of cells attached to microspheres was ob-
served (P6 0.001). The addition of the scrambled
peptides had no appreciable e¡ect on these adhesive
interactions. In contrast, a small increase in adhesion
strength was observed in the presence of both the
consensus sequence and its scrambled counterpart.
3.4. Soluble heparin-binding peptides modulate
chemokinetic smooth muscle cell migration
In order to ensure comparable ¢bronectin surface
densities, the adsorption isotherms of ¢bronectin on
glass and non-tissue culture treated polystyrene sur-
faces were determined. Fibronectin adsorption pro-
¢les were similar on both surfaces (data not shown).
Although conformational di¡erences between ¢bro-
nectin adsorbed on glass and polystyrene may exist,
all assays were performed on surfaces coated at con-
centrations of pFN that exceed monolayer coverage.
To assess the e¡ect of competitively inhibiting the
interaction between cell surface heparan sulfate and
the underlying ¢bronectin substrate, soluble heparin-
binding peptides were added to serum-free medium
during the migration assay. Chemokinetic cell migra-
tion behavior was characterized at concentrations of
soluble peptide ranging from 1 to 500 WM. In the
presence of the vWF-derived peptide, a biphasic de-
pendence of cell speed with soluble peptide concen-
tration was observed (Fig. 5). At a concentration of
1 WM, the speed of the migrating cells increased by
nearly 20% (P6 0.05), with small decreases in speed
noted at higher peptide concentrations. A concomi-
tant reduction in persistence time (P6 0.05) was also
Fig. 3. Disassembly of focal adhesion by competitive inhibition with heparin-binding consensus sequence peptide
(AKRGLRHRLGRKG). PAC1 cells seeded on pFN-coated glass coverslips were stained for vinculin to visualize focal adhesion after
a 24 h treatment using the consensus peptide. The concentrations used were: no treatment (A), 1 WM consensus (B), 100 WM consen-
sus (C), and 100 WM scrambled consensus (KLKLRARGRGRGH) (D).
Table 1
Cell^substrate adhesive strength in the presence or absence of
heparin-binding peptides or scrambled sequences
Treatment F50 (g)
None 490 þ 100
vWF (100 WM) 78 þ 102
Scrambled vWF (100 WM) 502 þ 32
Consensus (100 WM) 611 þ 5
Scrambled consensus (100 WM) 629 þ 42
2P6 0.001.
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observed at 1 WM. Although statistical signi¢cance
was not achieved, the percent of cells that were mo-
tile decreased with increasing vWF peptide concen-
tration. For example, in the presence of 500 WM
vWF peptide, the percent of motile cells decreased
from approximately 60 to 40%. No signi¢cant e¡ect
was observed with the addition of scrambled vWF
peptide sequence at any peptide concentration (data
not shown).
In contrast to the vWF peptide sequence, the ad-
dition of the consensus peptide to the migration me-
dium served to decrease cell migration speed while
increasing the percent of motile cells (Fig. 6). In the
presence of 500 WM consensus peptide, the speed of
the migrating cells decreased by over 30% while the
fraction of motile cells increased by approximately
20%. Previously, we have shown that an increase in
¢bronectin surface density results in a decrease in the
migration speed of motile endothelial cells, but was
accompanied by an increase in the fraction of motile
cells [28]. Indeed, the e¡ect of the consensus peptide
on cell migration is consistent with an increase in
surface ligand density. As noted, adsorption of the
consensus peptide sequence to ¢bronectin-coated sur-
faces exceeded that observed with the vWF peptide
and an unexpected increase in cell adhesion strength
in the presence of this peptide was evident. Thus, the
unique e¡ect of this consensus peptide on cell migra-
tion may be due to direct adsorption to an under-
lying substrate with an increase in the surface density
of heparin-binding sites.
4. Discussion
The migration of mesenchymal cells in the vascular
wall, in association with the reorganization of ¢bril-
lar protein networks, contributes to regional tissue
remodeling with the potential of lesion formation
[32^34]. For example, studies in rat, porcine, and
baboon models of arterial balloon injury have dem-
onstrated a direct relationship between smooth
muscle cell or myo¢broblast migration and restenosis
[12,35,36]. A general requirement for cell migration is
some form of cell adhesive contact connecting both
cell membrane and cytoskeleton with the surround-
ing substratum. In this regard, recent evidence sug-
gests that cell surface heparan sulfate proteoglycans,
Fig. 4. E¡ect of heparin-binding peptides on cell adhesion. The
adhesive strength of PAC1 cells was assessed before and after
treatment with heparin-binding peptides. In (A), an adhesion
pro¢le was determined in the absence of added peptide. In (B),
cells were exposed to 100 WM/ml of vWF (R) or scrambled
vWF peptide (b) and in (C), cells were exposed to 100 WM/ml
of consensus sequence peptide (R) or a scrambled peptide con-
trol (b).
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in particular syndecans 1 and 4, are important deter-
minants of cell/matrix adhesive processes. For exam-
ple, Sanderson and colleagues [37] have demon-
strated that the expression of syndecan 1 in a
human myeloma cell line limits its ability to form
tumors in vivo. In addition, Carey et al. [38] have
shown that overexpressing syndecan 1 induces cell
spreading and the development of micro¢lament
bundles which terminate in focal adhesions. This be-
havior has been further correlated with an inability
of syndecan 1 expressing cells to invade collagen ma-
trices [39]. These reports have suggested that the mi-
gration of at least some cell types may require the
loss of syndecan 1 HSPG receptors [37,39].
Notably, syndecan 4 is the only HSPG incorpo-
rated into focal adhesions, where it colocalizes with
L1 and L3 integrin subunits and secreted ¢bronectin
¢brils [40,41]. Indeed, during the formation of focal
adhesions syndecan 4 becomes clustered into higher
order, self-associating structures which appear to be
linked to the cytoskeleton. With this in mind, a cur-
rent view holds that focal adhesions form in two
stages [9]. The ¢rst stage is dependent upon integrin
activation and clustering, includes aggregation of
vinculin, talin, paxillin, tensin, ¢lamin, and K-actinin,
and requires the activation of protein kinase C
(PKC) and focal adhesion kinase. The second stage
is mediated by interaction of syndecan 4 with hepa-
rin-binding domains in the ECM and, likewise, in-
volves PKC signaling [41]. In support of a possible
role of syndecan 4 in cell locomotion, Woods et al.
[42] have recently reported that overexpression of
Fig. 5. The e¡ect of vWF peptide (KDRKRPSELRRI) on PAC1 cell migration. PAC1 cells were treated with the vWF-derived pep-
tide sequence in doses ranging from 0.1 to 500 WM. Cell motility was characterized in terms of cell speed (A), persistence time (B),
dispersion coe⁄cient (C) and percent of motile cells (D). The data are presented as means þ S.E.M. of at least 100 cells (*P6 0.05).
Treatment with the scrambled vWF peptide sequence (IKERPRLKDRSR) had no e¡ect on cell speed or the percentage of motile
cells.
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syndecan 4 in CHO-K1 cells limits cell migration.
These studies have provided signi¢cant insight into
a potentially important function of cell surface hep-
aran sulfate proteoglycans. Nonetheless, it bears em-
phasis that a primary change in substratum adhesive-
ness could initiate signi¢cant changes in motile cell
behavior ^ even in the absence of a requisite change
in the surface concentration or binding a⁄nity of
heparan sulfate. Speci¢cally, the functional conse-
quences of syndecan 1 or 4 expression must be inter-
preted within the context of the type, distribution,
and spatial density of adhesive ligands, as well as
the ability of cell surface receptors to e¡ectively in-
teract with available matrix bound ligands.
It is likely that syndecans 1 and 4 in£uence cell
motility and remodeling processes by direct contact
mediated interactions between core protein associ-
ated heparan sulfate chains with heparin-binding do-
mains found within matrix glycoproteins. For exam-
ple, at least two domains within each ¢bronectin
monomer bind to heparan sulfate [43]. The HEPI
site is located at the N-terminus, is composed of
type I repeat units, and is associated with a relatively
weak heparin dissociation constant in the range 1036
to 1035 M [44,45]. The other major heparin-binding
site, known as HEPII, is located in three type III
repeat units (nos. 12^14) between the cell-binding
(RGD) site and the variably spliced IIICS region
(domain V) near the C-terminus. At least four inde-
pendent sites consisting of basically charged amino
acids may mediate heparin binding within the HEPII
domain; none of which overlaps with integrin-bind-
ing sites. The heparin dissociation constant for HEP-
II is considerably greater than HEPI: in the range of
Fig. 6. The e¡ect of the consensus peptide sequence (AKRGLRHRLGRKG) on PAC1 cell migration. PAC1 cells treated with peptide
in doses ranging from 1.0 to 500 WM. Cell motility was characterized in terms of cell speed (A), persistence time (B), dispersion coe⁄-
cient (C) and percent of motile cells (D). The data are presented as means þ S.E.M. of at least 100 cells (*P6 0.05). Treatment with
the scrambled consensus peptide sequence (KLKLRARGRGRGH) had no e¡ect on cell speed or the percentage of motile cells.
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1038 to 1037 M [44,45]. Recently, Gallagher and
colleagues [46] have identi¢ed a likely HEPII-binding
site in heparan sulfate characterized by sequences of
N-sulfated disaccharides in which a proportion of the
iduronate residues are sulfated at C-2. Of note, this
glycosaminoglycan sequence bears close similarity to
the reported binding sequences for both vWF and
FGF-2 [46,47]. The heparin-binding domain for
vWF has been localized to a 23 amino acid region
Tyr565^Ala587 with all of the binding a⁄nity local-
ized to a central 12 residue fragment, Tyr569^I580
[26]. This sequence has a central cluster of basic res-
idues (RKR), £anked on the upstream and down-
stream sides by the basic residues K and RR, respec-
tively. The heparin dissociation constant for this
sequence is 5U1037 M. Although signi¢cantly higher
than that observed for FGF-2 (1039 M), it approx-
imates that of native vWF and HEPII. All of this
suggests that competing interactions may take place
between heparin-binding proteins or peptides and
common high a⁄nity sites on the heparan sulfate
chain. Likely, both protein a⁄nity and concentration
will determine the end result of these interactions. It
has been postulated that competing mechanisms of
this kind may play a signi¢cant role in the control
and integration of cellular responses to growth fac-
tors and the ECM. However, con¢rmatory evidence
in support of this hypothesis has been limited. Our
results indicate that a heparin-binding peptide de-
rived from vWF may limit the formation and/or in-
duce the disassembly of focal adhesions, as assessed
by immunohistochemical staining. These observa-
tions were consistent with an observed dose-depen-
dent decrease in cell^substrate adhesive strength and
a biphasic e¡ect on migration speed. The competitive
nature of these interactions was also demonstrated
by the inability of scrambled peptide sequences to
mediate these e¡ects.
It is noteworthy that of the tested soluble heparin-
binding peptides not all were capable of mediating
e¡ective competitive interactions that had an e¡ect
on either cell adhesion or motility. A heparin-binding
consensus sequence (AKRGLRHRLGRKG) with a
heparin dissociation constant of 1037 M had no sig-
ni¢cant e¡ect on either cell adhesion or migration at
concentrations of up to 100 WM. At a concentration
of 500 WM, the consensus sequence did induce a sig-
ni¢cant decrease in cell speed and dispersion. This
may have been related to an observed increase in
binding of this peptide to ¢bronectin-coated surfaces
which, as a consequence, may have augmented the
surface concentration of heparin-binding sites. None-
theless, these data suggest that non-speci¢c binding
of the vWF-derived peptide to heparan sulfate chains
is not responsible for the observed e¡ect on cell ad-
hesion and motility. Rather, our observations suggest
competitive binding interactions between heparin-
binding domains of the vWF peptide or the ¢bronec-
tin HEPII domain and unique oligosaccharide se-
quences on the GAG chain.
The integration of chemical and mechanical signals
from the matrix directly in£uences cell adhesive and
motility behavior and, as an end result, tissue mor-
phogenesis. Other mechanisms that modulate focal
adhesion formation and disassembly have been well
documented, including thrombospondin^calreticulin
and tenascin C^annexin II interactions, among
others [48]. However, our data suggest that compet-
itive binding interactions between heparin-binding
peptides and cell surface GAG chains may also in-
£uence wound healing and other processes, in part,
by modulating cell adhesion and migration behavior.
Admittedly, while these investigations have not de-
termined the physiological relevance of vWF peptide
fragments, a growing body of literature has docu-
mented that a variety of matrix protein degradation
products do have physiologically signi¢cant biologi-
cal activity. Speci¢cally, a large number of reports
have observed that soluble ¢bronectin fragments reg-
ulate both in£ammatory cytokines, as well as matrix
metalloproteinase expression and activity in a variety
of cell types including chondrocytes and epithelial
cells [49^51]. In particular, elevated levels of ¢bro-
nectin fragments have been observed in the joint £uid
of patients with osteoarthritis and their role in the
initiation and ampli¢cation of this disease process
appears to be quite likely [52,53]. Similar pro-in£am-
matory e¡ects have also been observed in association
with peptides derived from elastin and collagen with
potential pathophysiological relevance to aortic
aneurysm formation [54^56]. Finally, the capacity
of ¢bronectin, ¢brinogen, and collagen protein frag-
ments to regulate angiogenesis has been illustrated by
a number of investigators, which may hold particular
signi¢cance to tumor formation, retinopathy, and
wound healing [57^59]. All of these observations im-
BBAMCR 14830 5-2-02
J.H. Chon, E.L. Chaikof / Biochimica et Biophysica Acta 1542 (2002) 195^208 205
ply that matrix protein cleavage fragments may play
important roles in normal tissue remodeling, inate
immune responses, as well as in disease pathophysi-
ology.
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